These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37422608)

  • 41. Linguistic and content validation of a German-language PRO-CTCAE-based patient-reported outcomes instrument to evaluate the late effect symptom experience after allogeneic hematopoietic stem cell transplantation.
    Kirsch M; Mitchell SA; Dobbels F; Stussi G; Basch E; Halter JP; De Geest S
    Eur J Oncol Nurs; 2015 Feb; 19(1):66-74. PubMed ID: 25190633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation Between Remote Symptom Reporting by Caregivers and Adverse Clinical Outcomes: Mixed Methods Study.
    Oakley-Girvan I; Yunis R; Fonda SJ; Longmire M; Veuthey TL; Shieh J; Aghaee S; Kubo A; Davis SW; Liu R; Neeman E
    J Med Internet Res; 2023 Nov; 25():e49100. PubMed ID: 37988151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Feasibility Assessment of Using the Complete Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library.
    Shepshelovich D; McDonald K; Spreafico A; Razak ARA; Bedard PL; Siu LL; Minasian L; Hansen AR
    Oncologist; 2019 Apr; 24(4):e146-e148. PubMed ID: 30728278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients-Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE).
    Pappot H; Baeksted C; Knoop A; Mitchell SA; Nissen A; Johansen C
    Breast J; 2019 Mar; 25(2):269-272. PubMed ID: 30761667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.
    Reeve BB; McFatrich M; Pinheiro LC; Weaver MS; Sung L; Withycombe JS; Baker JN; Mack JW; Waldron MK; Gibson D; Tomlinson D; Freyer DR; Mowbray C; Jacobs S; Palma D; Martens CE; Gold SH; Jackson KD; Hinds PS
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27650708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study.
    Veldhuijzen E; Walraven I; Belderbos J
    JMIR Cancer; 2021 Sep; 7(3):e26574. PubMed ID: 34519658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multicenter Prospective Cohort Study of the Patient-Reported Outcome Measures PRO-CTCAE and CAT EORTC QLQ-C30 in Major Abdominal Cancer Surgery (PATRONUS): A Student-Initiated German Medical Audit (SIGMA) Study.
    ; Mihaljevic AL
    Ann Surg Oncol; 2021 Jun; 28(6):3075-3089. PubMed ID: 33683524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study.
    Matthies LM; Taran FA; Keilmann L; Schneeweiss A; Simoes E; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Lux MP; Schuetz F; Fasching PA; Sohn C; Brucker SY; Graf J; Wallwiener M
    J Med Internet Res; 2019 Jan; 21(1):e10004. PubMed ID: 30668517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy.
    Knoerl R; Gray E; Stricker C; Mitchell SA; Kippe K; Smith G; Dudley WN; Lavoie Smith EM
    Support Care Cancer; 2017 Nov; 25(11):3437-3446. PubMed ID: 28577231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PRO-CTCAE reveals under-recognition of dermatologic symptom burden in hospitalized cancer patients.
    Gu S; Menzer C; Hay JL; Pena C; Dusza S; Lacouture ME; Markova A
    Support Care Cancer; 2023 May; 31(6):337. PubMed ID: 37183206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials.
    Veitch ZW; Shepshelovich D; Gallagher C; Wang L; Abdul Razak AR; Spreafico A; Bedard PL; Siu LL; Minasian L; Hansen AR
    J Natl Cancer Inst; 2021 Aug; 113(8):980-988. PubMed ID: 33616650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
    Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
    J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer.
    Filho OM; Giobbie-Hurder A; Lin NU; Faggen M; Come S; Openshaw T; Constantine M; Walsh J; Freedman RA; Schneider B; Burstein HJ; Mayer EL
    Breast Cancer Res Treat; 2021 Jan; 185(1):135-144. PubMed ID: 33025482
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient reported outcomes interfering with daily activities in prostate cancer patients receiving antineoplastic treatment.
    Stormoen DR; Baeksted C; Taarnhøj GA; Johansen C; Pappot H
    Acta Oncol; 2021 Apr; 60(4):419-425. PubMed ID: 33641578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electronic Patient-Reported Outcome Measures Evaluating Cancer Symptoms: A Systematic Review.
    Pérez-Alfonso KE; Sánchez-Martínez V
    Semin Oncol Nurs; 2021 Apr; 37(2):151145. PubMed ID: 33773879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Patient-Reported Outcomes Thermometer-5-Item Scale (5T-PROs): Validation of a New Tool for the Quick Assessment of Overall Health Status in Painful Rheumatic Diseases.
    Salaffi F; Di Carlo M; Carotti M; Farah S
    Pain Res Manag; 2018; 2018():3496846. PubMed ID: 30425755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx).
    Cheng HL; Molassiotis A
    Asia Pac J Clin Oncol; 2019 Feb; 15(1):56-62. PubMed ID: 29873180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation and reliability testing of the Breast-Q latissimus dorsi questionnaire: cross-cultural adaptation and psychometric properties in a Swedish population.
    Kamya L; Hansson E; Weick L; Hansson E
    Health Qual Life Outcomes; 2021 Jul; 19(1):174. PubMed ID: 34217326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure.
    Feldman E; Pos FJ; Smeenk RJ; van der Poel H; van Leeuwen P; de Feijter JM; Hulshof M; Budiharto T; Hermens R; de Ligt KM; Walraven I
    ESMO Open; 2023 Feb; 8(1):100775. PubMed ID: 36652781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Modular Health-Related Quality of Life Instrument for Electronic Assessment and Treatment Monitoring: Web-Based Development and Psychometric Validation of Core Thrive Items.
    Wicks P; McCaffrey S; Goodwin K; Black R; Hoole M; Heywood J
    J Med Internet Res; 2019 Jan; 21(1):e12075. PubMed ID: 30681962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.